Unique and selective small molecules to dissect histone acetyltransferase biology

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1080146

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

A class of enzymes called histone acetyltransferases appear to be important in a variety of diseases, from inflammation to cancer. We are developing potent and selective compounds that will be able to tell us which of these enzymes may be targets for cancer, and which for inflammatory disorders. This will be invaluable for better treatment of debilitating human diseases with unmet needs.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $694,255.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Biologically Active Molecules

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

acute myeloid leukaemia (AML) | drug discovery | epigenetics | medicinal chemistry | rational drug design

Related Links